MIRM

Mirum Pharmaceuticals
MIRM

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$1.94B
EV
$1.98B
Shares Outstanding
56.39M
Beta
1.01

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$64.80
P/E 2025E
-
P/Revenue 2025E
4.54x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Mirum Pharmaceuticals, Inc.

gainify
MIRM

Mirum Pharmaceuticals, Inc.

MIRM

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Its lead product candidate is LIVMARLI (maralixibat), an orally administered and minimally absorbed...

Sector

Healthcare

Industry

Biotechnology

CEO

Peetz, Christopher

Employees

322

IPO Date

2019-07-18

Headquarters

950 Tower Lane, Suite 1050, Foster City, California, 94404, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved